Could be this?
Leronlimab is a monoclonal antibody knocking on the door of an Emergency Use Authorization (EUA) from the FDA. President Trump has scheduled a press conference today to announce a breakthrough therapy. It has to be Leronlimab whose owner, CytoDyn (CYDY) just presented favorable data from a double blinded placebo controlled study. It is the only drug to have done so. The drug showed efficacy and safety in a difficult population to address: mild to moderate patients. So while Gileads (GILD) Remdesivir (the only other drug with an EUA for Covid), remains controversial, theres an opening for something better and Leronlimab certainly is that.
Maybe so!
Thanks for posting that/that link :-)
And, the page, at your link was removed.....just like that :(